Morgan Stanley »

Coeptis Therapeutics Hldgs I shares owned by Morgan Stanley

Quarter-by-quarter ownership of Coeptis Therapeutics Hldgs I (COEP) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Coeptis Therapeutics Hldgs I

Tip: Access up to 7 years of quarterly data

All positions including Coeptis Therapeutics Hldgs I held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Coeptis Therapeutics Hldgs I by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.3k 201 11.22
2025-12-31 $2.9k 200 14.25
2025-09-30 $3.5k 200 17.46

More positions owned by Morgan Stanley

Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p500 Etf (IVV)
Tesla Motors (TSLA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Eli Lilly & Co. (LLY)
Visa Com Cl A (V)

View all positions for Morgan Stanley

Top funds holding Coeptis Therapeutics Hldgs I

Vanguard Group
Vanguard Capital Management
Geode Capital Management
State Street Corporation
Vanguard Fiduciary Trust
United Capital Financial Advisers
Marshall Wace
BlackRock
Northern Trust
Steward Partners Investment Advisory
Vanguard Global Advisers
Morgan Stanley
Advisor Group Holdings
SageView Advisory Group
Barclays

View all funds holding Coeptis Therapeutics Hldgs I